Sign inJoin waitlistJoin the waitlist

KK

Kevin Kim

Physician · San Francisco Oncology Associates Medical Group Inc

Credentials: · · · ·

History

San Francisco Oncology Associates Medical Group Inc
Present

Hand Surgery
University of Connecticut School of Medicine
2000–2001
Medical Oncology
1998–2000
Internal Medicine
1995–1998
University of Illinois College of Medicine
1991–1995

Research

Inhibition of mutated, activated BRAF in metastatic melanoma
New England Journal of Medicine · 2010 · 2,847 citations
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
New England Journal of Medicine · 2012 · 2,234 citations
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib
New England Journal of Medicine · 2012 · 1,763 citations

Patrick Hwu
44 papers
AB
Agop Bedikian
38 papers
NP
Nicholas Papadopoulos
38 papers
WH
Wen-Jen Hwu
32 papers
Mohammed Kashani-Sabet
21 papers
Michael Davies
18 papers
Victor Prieto
17 papers
Sapna Patel
16 papers
GF
Gerald Falchook
15 papers
Jade Homsi
15 papers
Jeffrey Sosman
15 papers
Stanley Leong
15 papers

Clinical trials

Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation
Principal investigator · Unknown · Phase 2
California Pacific Medical Center Research Institute
2021–2024
Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation
Principal investigator · Unknown · Phase 2
California Pacific Medical Center Research Institute
2019–2023
Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation
Principal investigator · Suspended · Phase 1
Piramal Enterprises Limited
2013–2016
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
Principal investigator · Completed · Phase 1
AstraZeneca
2007–2025